Literature DB >> 2615931

Comparison of the effects of lamotrigine and phenytoin on the EEG power spectrum and cortical and brainstem-evoked responses of normal human volunteers.

A van Wieringen1, C D Binnie, J W Meijer, A W Peck, J de Vries.   

Abstract

Phenytoin and lamotrigine (a new antiepileptic drug with an animal experimental profile resembling phenytoin) have closely similar effects on the quantitative pharmaco-electroencephalogram. These characteristics do not provide a basis for the functional classification of antiepileptic drugs nor for prediction of clinical efficacy, but they do give some insight into the probable secondary psychotropic effects which may arise with use of these drugs. Central conduction in cortical (visual) and brainstem (auditory) event-related potentials are not influenced by either drug, but peripheral nerve conduction is delayed with the use of phenytoin as reflected in increased latency wave I in the brainstem auditory-evoked response. The evidence suggests that in equivalent therapeutic dosage, lamotrigine may be less neurotoxic than phenytoin.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2615931     DOI: 10.1159/000118570

Source DB:  PubMed          Journal:  Neuropsychobiology        ISSN: 0302-282X            Impact factor:   2.328


  3 in total

1.  Interaction of the antiepileptic drug lamotrigine with recombinant rat brain type IIA Na+ channels and with native Na+ channels in rat hippocampal neurones.

Authors:  X Xie; B Lancaster; T Peakman; J Garthwaite
Journal:  Pflugers Arch       Date:  1995-07       Impact factor: 3.657

Review 2.  Quantitative Pharmaco-Electroencephalography in Antiepileptic Drug Research.

Authors:  Yvonne Höller; Christoph Helmstaedter; Klaus Lehnertz
Journal:  CNS Drugs       Date:  2018-09       Impact factor: 5.749

3.  Development of antipsychotic medications with novel mechanisms of action based on computational modeling of hippocampal neuropathology.

Authors:  Peter J Siekmeier; David P vanMaanen
Journal:  PLoS One       Date:  2013-03-19       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.